Neil Cashman

Neil Cashman

Company: ProMIS Neurosciences

Job title: Chief Scientific Officer & Co-founder

Seminars:

Chair’s closing remarks 4:30 pm

Read more

day: Day Two

Generating Effective Therapeutic Strategies for Sporadic Disease with Gene Therapies in ALS 2:00 pm

Gene therapies for sporadic disease: an emerging concept Understanding heterogeneity of disease mechanisms Translating improving understanding of ALS pathogenesis to identify promising targetsRead more

day: Day Two

Chair’s Opening Remarks 8:25 am

Read more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.